Kronox Lab Sciences

146.31
+0.74
(0.51%)
Market Cap
542.90 Cr
EPS
5.81
PE Ratio
21.72
Dividend Yield
0.34 %
Industry
Chemicals
52 Week High
228.88
52 Week Low
138.14
PB Ratio
7.05
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,850.95
#1 1,45,012.90
72.31
12,522.60
#1 5.69
#1 1,747
9.04
58.97
2,981.60
88,382.00
77.05
13,221.50
-11.53
1,336
6.99
57.58
3,955.35
43,449.50
94.96
4,387.70
-25.09
435
57.50
57.73
2,032.95
27,728.00
40.15
7,757.90
-3.26
811
-51.46
51.04
454.90
22,457.60
43.56
4,227.40
0.66
411
29.69
56.13
4,246.75
21,052.60
79.76
2,120.90
0.37
271
7.18
61.77
4,554.80
19,715.70
#1 32.68
#1 13,843.30
-
563
-26.05
53.13
5,827.15
17,156.20
41.30
4,783.90
-13.69
324
#1 62.41
51.09
1,567.80
16,252.70
42.10
1,938.80
-8.77
323
21.85
43.79
400.80
14,529.80
39.81
6,380.70
-3.61
417
-62.90
49.56

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
-6.26 %
Net Income Growth
30.49 %
Cash Flow Change
-11.44 %
ROE
-12.14 %
ROCE
-11.85 %
EBITDA Margin (Avg.)
34.90 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
TTM
Revenue
52
63
83
98
91
99
Expenses
39
48
63
74
62
63
EBITDA
13
16
21
24
30
36
Operating Profit %
23 %
24 %
24 %
23 %
32 %
35 %
Depreciation
1
2
2
2
1
1
Interest
0
0
0
0
0
0
Profit Before Tax
12
13
18
22
29
34
Tax
3
4
5
6
7
9
Net Profit
9
10
14
16
21
25
EPS in ₹
343.75
2.40
3.49
4.29
5.81
6.80

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
Total Assets
34
38
57
54
74
Fixed Assets
6
9
11
16
26
Current Assets
27
26
44
34
47
Capital Work in Progress
0
0
0
0
1
Investments
0
0
0
0
0
Other Assets
29
28
46
38
47
Total Liabilities
34
38
57
54
74
Current Liabilities
11
8
14
9
8
Non Current Liabilities
0
3
3
1
0
Total Equity
23
27
40
45
66
Reserve & Surplus
23
27
40
8
29
Share Capital
0
0
0
37
37

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
0
1
1
-0
0
Investing Activities
-4
-3
-8
-7
-17
Operating Activities
5
11
9
20
17
Financing Activities
-0
-7
-1
-13
0

Share Holding

% Holding
Nov 2023
Jan 2024
May 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
100.00 %
100.00 %
100.00 %
74.21 %
74.21 %
74.21 %
FIIs
0.00 %
0.00 %
0.00 %
1.56 %
0.55 %
0.48 %
DIIs
0.00 %
0.00 %
0.00 %
5.43 %
2.57 %
2.20 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
0.00 %
16.26 %
20.58 %
20.20 %
Others
0.00 %
0.00 %
0.00 %
2.54 %
2.09 %
2.90 %
No of Share Holders
9
9
9
31,450
39,792
38,489

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.35 0.00

Corporate Action

Announcements

Closure of Trading Window7 days ago
Disclosure Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 07, 2025
Integrated Filing (Financial)Feb 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 01, 2025
Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 01, 2025
Integrated Filing (Financial)Jan 31, 2025
Financial Results For The Quarter And Nine-Months Ended December 31 2024Jan 31, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday January 31 2025.Jan 31, 2025
Board Meeting Intimation for Considering The Unaudited Standalone Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 23, 2025
Disclosure Under Regulation 31A Of The SEBI (LODR) Regulations 2015Jan 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Closure of Trading WindowDec 27, 2024
UPDATE ON DEVELOPMENT STATUS OF UNIT-IVNov 13, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2024
Financial Results For The Quarter And Half Year Ended 30Th September, 2024Nov 12, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November, 2024Nov 12, 2024
Board Meeting Intimation for Considering The Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30, 2024Oct 30, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Closure of Trading WindowSep 25, 2024
Submission Of Voting Result As Per Regulation 44 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Sep 02, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 02, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 10, 2024
Notice Of The 15Th Annual General MeetingAug 08, 2024
Reg. 34 (1) Annual Report.Aug 08, 2024
Intimation Of Book Closure And Record Date Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Aug 07, 2024
Intimation Of Record Date For DividendAug 07, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2024
Results-Financial Results For The Quarter Ended 30Th June, 2024Aug 06, 2024
Board Meeting Outcome for Outcome For Outcome Of Board MeetingAug 06, 2024
Board Meeting Intimation for To Consider And Approve The Unudited Standalone Financial Results For Quarter Ended June 30, 2024Jul 29, 2024
Intimation Under Regulation 30(13) Of SEBI (LODR) Regulations, 2015Jul 16, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 04, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 01, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 29, 2024
Corporate Action-Board approves DividendJun 28, 2024
Results- Financail Results For The Quarter And Year Ended 31St March, 2024Jun 28, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th June, 2024Jun 28, 2024
Closure of Trading WindowJun 27, 2024
Board Meeting Intimation for To Consider And Approve The Audited Standalone Financial ResultsJun 20, 2024
Board Meeting Intimation for To Consider And Approve The Audited Standalone Financial ResultsJun 20, 2024
Closure of Trading WindowJun 15, 2024
Listing of Equity Shares of Kronox Lab Sciences LtdJun 10, 2024

Technical Indicators

RSI(14)
Neutral
44.15
ATR(14)
Less Volatile
8.08
STOCH(9,6)
Neutral
34.38
STOCH RSI(14)
Neutral
71.87
MACD(12,26)
Bullish
0.62
ADX(14)
Strong Trend
35.16
UO(9)
Bearish
39.66
ROC(12)
Downtrend But Slowing Down
-0.37
WillR(14)
Neutral
-62.36